---
title: "CVRx announces initiation of BENEFIT-HF trial of Barostim device in “significantly expanded population”"
date: "2026-01-26T23:04:42.000Z"
publishedDate: "26 janvier 2026"
summary: "CVRx recently announced the start of the BENEFIT-HF clinical trial, a randomized study designed to evaluate the impact of the Barostim neuromodulation device in a &#8220;significantly expanded heart failure population&#8221;, according to the company. The trial is supported by Centers for Medicare &#38; Medicaid Services (CMS) category B investigational device exemption (IDE) coverage, CVRx reported."
importance: ""
sourceUrl: "https://cardiovascularnews.com/cvrx-announces-initiation-of-benefit-hf-trial-of-barostim-device-in-significantly-expanded-population/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2026-01-26-cvrx-announces-initiation-of-benefit-hf-trial-of-barostim-device-in-significantly-expanded-population"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2026/01/Barostim-web.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/cvrx-announces-initiation-of-benefit-hf-trial-of-barostim-device-in-significantly-expanded-population/"
---

![CVRx announces initiation of BENEFIT-HF trial of Barostim device in “significantly expanded population”](http://cardiovascularnews.com/wp-content/uploads/sites/14/2026/01/Barostim-web.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/cvrx-announces-initiation-of-benefit-hf-trial-of-barostim-device-in-significantly-expanded-population/*

## L’essentiel

CVRx recently announced the start of the BENEFIT-HF clinical trial, a randomized study designed to evaluate the impact of the Barostim neuromodulation device in a &#8220;significantly expanded heart failure population&#8221;, according to the company. The trial is supported by Centers for Medicare &#38; Medicaid Services (CMS) category B investigational device exemption (IDE) coverage, CVRx reported.

## Lien source

https://cardiovascularnews.com/cvrx-announces-initiation-of-benefit-hf-trial-of-barostim-device-in-significantly-expanded-population/
